AIM
XERS icon

Ausbil Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

Ausbil Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,000
Closed -$290K – 76
2025
Q4 		$290K Buy
+37,000
New +$291K 0.17% 62

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ausbil Investment Management's XERS Position: Q1 2026 in Review

Ausbil Investment Management sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 37,000 shares — an estimated $290K sold.

Ausbil Investment Management first reported a position in XERS in Q4 2025 and held it in 1 quarter. The position peaked at $290K in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Ausbil Investment Management reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • Ausbil Investment Management sold 37,000 Xeris Biopharma Holdings shares in Q1 2026, an estimated $290K.
  • Ausbil Investment Management first reported a position in Xeris Biopharma Holdings in Q4 2025 and held it in 1 quarter.
  • Ausbil Investment Management's Xeris Biopharma Holdings position peaked at $290K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Ausbil Investment Management's 13F filing for Q1 2026, filed 8 Apr 2026.